Generalized Myasthenia Gravis

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS withdrawal · 2025-06-27
Clinical Trial Update: An Exploratory Clinical Study of GC012F Injection for Refractory gMG [EARLY_Phase 1]
An exploratory early-phase study evaluating GC012F injection for refractory generalized myasthenia gravis has been withdrawn.